Claims for Patent: 4,427,827

Summary for Patent: 4,427,827

Title:	Synthesis of hormone fragments
Abstract:	The yield of peptide synthesis processes of the type in which a protected intermediate resin peptide of the formula Resin--CH.sub.2 --O--Phe--X, Resin--CH.sub.2 --O--Gly--X, Resin--CH.sub.2 --O--Ala--X, or Resin--CH.sub.2 --O--Leu--X is deprotected, and successively protected amino acids are coupled to the resin peptide and deprotected, is increased significantly by deprotecting the first residue with trifluoroacetic acid and deprotecting the other residues with hydrogen chloride.
Inventor(s):	Stevenson; David (Scarsdale, NY)
Assignee:	USV Pharmaceutical Corporation (Tarrytown, NY)
Application Number:	06/435,581
Patent Claims:	1. In the synthesis of a resin peptide of the formula R--CH.sub.2 --O--Z, from an intermediate resin peptide of the formula R--CH.sub.2 --O--Y--X wherein R is an insoluble polystyrene resin; Y is a terminal amino acid residue selected from the group consisting of Phe, Gly, Leu and Ala; X is a protecting group in the .alpha.-amino position of Y; and Z is either a fragment (n-m) of human parathyroid hormone or an analog thereof in which Y is Phe and m is 34; Y is Gly and m is 12; or Y is Leu and m is 7, 11, 15, 24, or 28; and n is an integer from 1 to (m minus 1); or a fragment (n-m) of human calcitonin or an analog thereof in which Y is Phe and m is 5, 6, or 11; Y is Gly and m is 2, 10, 28, or 30; Y is Leu and m is 4 or 9; or Y is Ala and m is 26 or 31; and n is an integer from 1 to (m minus 1); wherein the residue Y is deprotected and neutralized and in succession each of the other amino acids whose residues comprise the fragment Z, each having a protecting group in the .alpha.-amino position, is coupled to the next preceding residue on the resin peptide and then deprotected and neutralized, the improvement comprising (a) deprotecting the residue Y with trifluoroacetic acid, and (b) deprotecting the other residues with hydrogen chloride dissolved in a solvent selected from the group consisting of dioxane and ethers containing from 4 to 6 carbon atoms. 2. In the synthesis of a resin peptide of the formula R--CH.sub.2 --O--Z, from an intermediate resin peptide of the formula R--CH.sub.2 --O--Y--X wherein R is an insoluble polystyrene resin; Y is a terminal amino acid residue selected from the group consisting of Phe, Gly, and Leu; X is a protecting group in the .alpha.-amino position of Y; and Z is a fragment (n-m) of human parathyroid hormone or an analog thereof in which Y is Phe and m is 34; Y is Gly and m is 12; or Y is Leu and m is 7, 11, 15, 24, or 28; and n is an integer from 1 to (m minus 1); wherein the residue Y is deprotected and neutralized and in succession each of the other amino acids whose residues comprise the fragment Z, each having a protecting group in the .alpha.-amino position, is coupled to the next preceding residue on the resin peptide and then deprotected and neutralized, the improvement comprising (a) deprotecting the residue Y with trifluoroacetic acid, and (b) deprotecting the other residues with hydrogen chloride dissolved in a solvent selected from the group consisting of dioxane and ethers containing from 4 to 6 carbon atoms. 3. The process of claim 1 wherein the hydrogen chloride has a concentration of about 3.5 N to about 4.0 N and the solvent is dioxane. 4. The process of claim 3 wherein the hydrogen chloride solution also contains about 1 vol. % to about 2 vol. % of a thiol. 5. The process of claim 4 wherein the thiol is 2-mercaptoethanol. 6. The process of claim 1 wherein the protecting group removed in each deprotecting step is t-butyloxycarbonyl. 7. The process of claim 1 wherein the trifluoroacetic acid is dissolved in toluene, methylene chloride, or a mixture thereof. 8. The process of claim 1 wherein n is 1. 9. The process of claim 1 wherein Z is a fragment (28-34) of human parathyroid hormone, and Y is Phe. 10. The process of claim 1 wherein Z is a fragment (5-12) of human parathyroid hormone, and Y is Gly. 11. The process of claim 1 wherein Z is a human parathyroid hormone fragment, Y is Leu, m is 7, 11, 15, 24, or 28, and n is (m minus 6). 12. The process of claim 9 wherein the hydrogen chloride has a concentration of about 3.5 N to about 4.0 N and the solvent is dioxane. 13. The process of claim 10 wherein the hydrogen chloride has a concentration of about 3.5 N to about 4.0 N and the solvent is dioxane. 14. The process of claim 11 wherein the hydrogen chloride has a concentration of about 3.5 N to about 4.0 N and the solvent is dioxane.

Details for Patent 4,427,827

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2039-03-29